πŸ‡ΊπŸ‡Έ FDA
Patent

US 7244826

Internalizing ERB2 antibodies

granted A61KA61K31/704A61K38/00

Quick answer

US patent 7244826 (Internalizing ERB2 antibodies) held by The Regents of the University of California expires Mon Jul 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jul 17 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
32
CPC classes
A61K, A61K31/704, A61K38/00, A61K47/6809, A61K47/6843